« Back

FUNDING ANNOUNCEMENT: CARISMA CLOSES $53 MILLION SERIES A FINANCING

Jun 27, 2018
|
PDF Version

Carisma Therapeutics closes a $53Million Series A financing with top investors to develop novel CAR-Macrophage immunotherapies.